Challenge Conventional ThinkingView Our Research
What We Do
Prescience Point Capital Management conducts in-depth investigations of public companies, which often uncover fraud, misleading business practices or significant valuation issues. Unlike conventional investment research, we spend months on our analysis, dig deep into a company’s numbers, speak to industry experts and conduct on-the-ground due diligence to form our views. Our investment opinions are based on verifiable facts, not management’s representation of those facts.
Sign up for report updates
Eiad Asbahi, founder of Prescience Point, told Business Insider that a number of things signaled possible issues at Celadon, including its accounting practices, nepotism among…
Two former top executives at Celadon Group Inc have been charged with fraud and lying to auditors by concealing losses in the trucking company’s aging…
March 17, 2020
Medallia, Inc. | Update 1
We remain short Medallia, Inc. (MDLA) as the company has used M&A to mask rapidly deteriorating organic revenue growth. We believe fair value is >35% below current levels.
January 16, 2020
Medallia, Inc. | MDLA
We are short Medallia Inc. (MDLA) with 108 million shares coming off lock-up, Medallia faces the inevitable reality of its stock price converging with fundamental value
December 10, 2019
Broadmark Realty Capital Inc. | BRMK
Broadmark Realty Capital, Inc. (BRMK) offers immediate upside as a temporary market inefficiency dissipates. We are long BRMK.
March 6, 2019
Kellogg Company | Update 2
In our latest report on Kellogg Company we are reiterating and updating our thesis based on Kellogg’s Q4 18 results and FY 19 guidance.
January 8, 2019
MiMedx Group Inc. | MDXG
Prescience Point believes that MiMedx shares offer one of the most attractive investment opportunities we have ever identified. We are long MDXG.